Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
50.60
0.46 (0.92%)
At close: Aug 15, 2025, 10:01 AM

Anbio Biotechnology Class A Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
2.37M 2.25M 10.01M 2.54M
Depreciation & Amortization
n/a 12.06K 6.25K n/a
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-1.57M 907.97K -5.41M 473.15K
Other Non-Cash Items
-337.1K -163.39K -40.87K n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
44.65K -1.2M -5.53M 1.65M
Operating Cash Flow
2.08M 898.37K 4.45M 4.18M
Capital Expenditures
n/a n/a -2.88 n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-35.47M -18.54M -16.09M n/a
Sales Maturities Of Investments
35.8M 20.27M 14.56M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
337.1K 1.73M -1.53M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-344.61K -42.84K n/a n/a
Financial Cash Flow
-344.61K -42.84K n/a n/a
Net Cash Flow
2.07M 2.59M 2.92M 4.18M
Free Cash Flow
2.08M 898.37K 4.45M 4.18M